Chien‐Lin Lu

1.4k total citations
54 papers, 1.0k citations indexed

About

Chien‐Lin Lu is a scholar working on Nephrology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Chien‐Lin Lu has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 16 papers in Pathology and Forensic Medicine and 11 papers in Molecular Biology. Recurrent topics in Chien‐Lin Lu's work include Parathyroid Disorders and Treatments (14 papers), Vitamin D Research Studies (13 papers) and Dialysis and Renal Disease Management (10 papers). Chien‐Lin Lu is often cited by papers focused on Parathyroid Disorders and Treatments (14 papers), Vitamin D Research Studies (13 papers) and Dialysis and Renal Disease Management (10 papers). Chien‐Lin Lu collaborates with scholars based in Taiwan, United States and China. Chien‐Lin Lu's co-authors include Kuo‐Cheng Lu, Cai‐Mei Zheng, Yi‐Chou Hou, Wen-Chih Liu, Min-Tser Liao, Chia‐Chao Wu, Yuh‐Feng Lin, Jia-Fwu Shyu, Ming‐Chieh Ma and Chun‐Hou Liao and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Bone and Mineral Research and Nutrients.

In The Last Decade

Chien‐Lin Lu

51 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien‐Lin Lu Taiwan 20 369 273 215 125 125 54 1.0k
Wen-Chih Liu Taiwan 21 401 1.1× 267 1.0× 186 0.9× 115 0.9× 71 0.6× 41 1000
Suzanne Heemskerk Netherlands 19 439 1.2× 287 1.1× 94 0.4× 137 1.1× 16 0.1× 28 1.3k
R. Swaminathan United Kingdom 19 284 0.8× 336 1.2× 116 0.5× 94 0.8× 49 0.4× 68 1.3k
Alessandra Mingione Italy 16 124 0.3× 285 1.0× 59 0.3× 79 0.6× 29 0.2× 33 888
Vinita Mishra United Kingdom 12 156 0.4× 218 0.8× 90 0.4× 162 1.3× 49 0.4× 29 816
Edgar Delvin Canada 25 161 0.4× 288 1.1× 600 2.8× 382 3.1× 156 1.2× 64 2.0k
Michihiro Hosojima Japan 16 329 0.9× 231 0.8× 135 0.6× 61 0.5× 10 0.1× 50 843
M D Nyby United States 17 601 1.6× 353 1.3× 319 1.5× 150 1.2× 52 0.4× 29 1.5k
Ming‐Chia Hsieh Taiwan 24 139 0.4× 434 1.6× 77 0.4× 49 0.4× 16 0.1× 76 1.5k
Gaia Chiara Mannino Italy 18 135 0.4× 414 1.5× 128 0.6× 106 0.8× 15 0.1× 68 1.3k

Countries citing papers authored by Chien‐Lin Lu

Since Specialization
Citations

This map shows the geographic impact of Chien‐Lin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Lin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Lin Lu more than expected).

Fields of papers citing papers by Chien‐Lin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Lin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Lin Lu. The network helps show where Chien‐Lin Lu may publish in the future.

Co-authorship network of co-authors of Chien‐Lin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Lin Lu. A scholar is included among the top collaborators of Chien‐Lin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Lin Lu. Chien‐Lin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Ming‐Hsien, et al.. (2025). Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection. Diabetes Obesity and Metabolism. 27(11). 6188–6199. 1 indexed citations
2.
Wang, Joshua, et al.. (2025). Analyzing clinical laboratory data outcomes in retrospective cohort studies using TriNetX. Biochemia Medica. 35(3). 353–360.
4.
Yiang, Giou‐Teng, Chia‐Chao Wu, Chien‐Lin Lu, et al.. (2023). Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment. Viruses. 15(1). 156–156. 7 indexed citations
5.
Hou, Yi‐Chou, Cai‐Mei Zheng, Hui‐Wen Chiu, et al.. (2022). Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease. Pharmaceuticals. 15(8). 952–952. 13 indexed citations
6.
Liao, Min-Tser, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, et al.. (2021). Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. Antioxidants. 10(9). 1440–1440. 33 indexed citations
7.
Hou, Yi‐Chou, Chuen‐Lin Huang, Chien‐Lin Lu, et al.. (2021). The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease. Frontiers in Aging Neuroscience. 13. 657794–657794. 14 indexed citations
8.
Liu, Wen-Chih, Jia-Fwu Shyu, Yuh‐Feng Lin, et al.. (2020). Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway. International Journal of Molecular Sciences. 21(20). 7483–7483. 30 indexed citations
9.
Liu, Wen-Chih, Jia-Fwu Shyu, Paik‐Seong Lim, et al.. (2020). Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor. International Journal of Molecular Sciences. 21(10). 3486–3486. 29 indexed citations
10.
Chiu, Hui‐Wen, Yi‐Chou Hou, Chien‐Lin Lu, et al.. (2020). Cinacalcet Improves Bone Parameters Through Regulation of Osteoclast Endoplasmic Reticulum Stress, Autophagy, and Apoptotic Pathways in Chronic Kidney Disease–Mineral and Bone Disorder. Journal of Bone and Mineral Research. 37(2). 215–225. 9 indexed citations
11.
Lu, Chien‐Lin, Kuo-Chin Hung, Pei‐Chen Wu, et al.. (2019). The Paradoxical Role of Uric Acid in Osteoporosis. Nutrients. 11(9). 2111–2111. 91 indexed citations
12.
Zheng, Cai‐Mei, Yung-Ho Hsu, Chia‐Chao Wu, et al.. (2019). Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease. International Journal of Molecular Sciences. 20(11). 2800–2800. 11 indexed citations
13.
Zheng, Cai‐Mei, Chia‐Chao Wu, Chi‐Feng Hung, et al.. (2018). Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients. Nutrients. 10(2). 196–196. 13 indexed citations
14.
Lu, Chien‐Lin, Jia-Fwu Shyu, Chia‐Chao Wu, et al.. (2018). Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion. Nutrients. 10(9). 1164–1164. 16 indexed citations
15.
Hou, Yi‐Chou, Chia‐Chao Wu, Min-Tser Liao, et al.. (2018). Role of nutritional vitamin D in osteoporosis treatment. Clinica Chimica Acta. 484. 179–191. 35 indexed citations
16.
17.
Lu, Chien‐Lin, Yuh‐Feng Lin, Jia-Fwu Shyu, et al.. (2016). Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis. International Journal of Medical Sciences. 13(5). 395–402. 10 indexed citations
18.
Lu, Chien‐Lin, Wen-Chih Liu, Cai‐Mei Zheng, et al.. (2016). Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients. International Journal of Medical Sciences. 13(3). 240–247. 21 indexed citations
19.
Liu, Wen-Chih, Cai‐Mei Zheng, Chien‐Lin Lu, et al.. (2015). Vitamin D and immune function in chronic kidney disease. Clinica Chimica Acta. 450. 135–144. 34 indexed citations
20.
Zheng, Cai‐Mei, Wen-Chih Liu, Min-Tser Liao, et al.. (2014). Metabolic Acidosis and Strong Ion Gap in Critically Ill Patients with Acute Kidney Injury. BioMed Research International. 2014. 1–8. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026